Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSTELLARE: Fluorescence Lymph Node Mapping in Right Hemicolectomy
NCT07060443Phase 2Recruiting
- Sponsor
- Pusan National University Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of indocyanine green in colon cancer (2 arms), sponsored by Pusan National University Hospital. Primary endpoint: Pathological D3 lymph node metastasis detection rate at 4 weeks. Started Jul 2025; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT07060443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07060443.